Comparative study between oxytocin versus combination of tranexamic acid and ethsmyslate in reducing intra operative bleeding during abdominal myomectomy

Role of oxytocin versus tranexamic acid and ethsmyslate in reducing intra operative blood loss in myomectomy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202008739887429

Enrollment

180

Registered

2020-08-24

Start date

2020-08-20

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

controlling bleeding after myomectomy

Interventions

Oxytocin

Tranexamic acid and Ethamsylate

saline

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: premenopausal patients aged between 30 to 50 years old, five or less symptomatic uterine myomas, maximum diameter of the largest myoma is 6 cm, all myomas are subserous or intramural and uterine size less than 24 weeks pregnancy

Exclusion criteria

Exclusion criteria: history of previous surgery, hypertension, cardiac and Pulmonary diseases, patients who have bleeding disorders, anemia (Hb 30 kg/m²) cases that require intraoperative conversion of myomectomy to hysterectomy

Design outcomes

Primary

Measure	Time frame
amount of blood loss	—

Secondary

Measure	Time frame
the need of blood and iron transfusion;duration of operation ;hospital stay;need for hysterectomy;postoperative fever	—

Countries

Egypt

Contacts

Public ContactMohamed Abd ElGawad

Medical student at faculty of medicine Fayoum university

mohammed.mahmod87@gmail.com+201069401202

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026